3-(4-bromophenylsulfonyl)propionic acid

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 3-(4-bromophenylsulfonyl)propionic acid
• 英文别名: 3-(4-Bromophenylsulfonyl)propanoic Acid；3-(4-Bromobenzenesulfonyl)propanoic acid；3-(4-bromophenyl)sulfonylpropanoic acid
• 化学式: C₉H₉BrO₄S
• mdl: MFCD00450485
• 分子量: 293.138
• InChiKey: VIZYBBUNMITQFV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  15
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.222
• 拓扑面积：
  79.8
• 氢给体数：
  1
• 氢受体数：
  4

文献信息

• Sulfone derivatives, process for their production and use thereof
  申请人：——

  公开号：US20030187023A1

  公开（公告）日：2003-10-02

  A compound represented by the formula: 1 wherein R is a cyclic hydrocarbon group, or the like; W is a bond, or the like; X is a divalent hydrocarbon group, or the like; Y and Z are each independently —N(R 6 )— or the like; ring A is a nitrogen-containing heterocyclic ring, or the like; R5 and R6 are independently hydrogen atom, a hydrocarbon group, or the like; Z′ is imidoyl group, or the like; a is 0, 1 or 2; and b is 0 or 1, or a salt thereof.

  一个由以下式表示的化合物： 其中R是一个环烃基团，或类似物；W是一个键，或类似物；X是一个二价碳氢基团，或类似物；Y和Z分别独立地为—N(R6)—或类似物；环A是一个含氮杂环环，或类似物；R5和R6独立地为氢原子、一个碳氢基团，或类似物；Z′是亚胺基团，或类似物；a为0、1或2；b为0或1，或其盐。
• [EN] HYDROXAMIC AND CARBOXYLIC ACID DERIVATIVES HAVING MMP AND TNF INHIBITORY ACTIVITY<br/>[FR] DERIVES DE L'ACIDE HYDROXAMIQUE ET DE L'ACIDE CARBOXYLIQUE DOTES D'UNE ACTIVITE INHIBITRICE VIS A VIS DES MMP ET DU TNF
  申请人：DARWIN DISCOVERY LIMITED

  公开号：WO1998005635A1

  公开（公告）日：1998-02-12

  (EN) The invention concerns hydroxamic acid and carboxylic acid derivatives of formulae (I): B-X-(CH2)n-CHR1-(CH2)m-CONHOH and (Ia): B-S(O)1-2-(CH2)n-CHR1-(CH2)m-COOR2, in which X is O, NR3 or S(O)0-2, and the other variables have the definitions given in the claims, having MMP and TNF inhibitory activity.(FR) La présente invention se rapporte à des dérivés de l'acide hydroxamique et de l'acide carboxylique, dotés d'une activité inhibitrice vis à vis des métalloprotéases matricielles (MMP) et du facteur de nécrose des tumeurs (TNF). Ces dérivés sont représentés par les formules (I): B-X-(CH2)n-CHR1-(CH2)m-CONHOH et (Ia): B-S(O)1-2-(CH2)n-CHR1-(CH2)m-COOR2, dans lesquelles X est O, NR3 ou S(O)0-2, les autres variables étant définies dans les revendications.

  该发明涉及式(I)和式(Ia)的羟胺酸和羧酸衍生物，具有MMP和TNF抑制活性，其中X为O、NR3或S(O)0-2，其他变量在权利要求中给出了定义。式(I)为B-X-(CH2)n-CHR1-( )m-CONHOH，式(Ia)为B-S(O)1-2-( )n-CHR1-( )m-COOR2。
• Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity
  申请人：——

  公开号：US20030207889A1

  公开（公告）日：2003-11-06

  Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity.

  具有MMP和TNF抑制活性的羟肟酸和羧酸衍生物。
• Imidazole derivative, process for producing the same, and use
  申请人：Kubo Keiji

  公开号：US20070004736A1

  公开（公告）日：2007-01-04

  There is provided an imidazole derivative useful as a thrombosis treating agent, which is represented by the formula (I): wherein R represents an optionally substituted cyclic hydrocarbon group or an optionally substituted heterocyclic group, W represents a bond or an optionally substituted divalent linear hydrocarbon group, X represents an optionally substituted divalent hydrocarbon group, Y represents —CO—, —S(O)—, —S(O) 2 — or a bond, ring A represents an optionally substituted pyrrolidine ring, an optionally substituted piperidine ring or an optionally substituted perhydroazepine ring, Z 1 and Z 3 independently represent a bond or an optionally substituted divalent linear hydrocarbon group, Z 2 represents —N(R 1 )—, —O—, —S(O)—, —S(O) 2 —, —CO—, —CH(R 1 )— or a bond, ring B represents an optionally substituted imidazole ring, wherein a substituent which the optionally substituted imidazole ring represented by ring B may have may be taken together with R 1 to form an optionally substituted ring, and a represents 0, 1 or 2.

  提供了一种咪唑衍生物，用作治疗血栓的药物，其化学式表示为(I)式：其中R代表可选取代的环烃基或可选取代的杂环基，W代表键或可选取代的二价直链烃基，X代表可选取代的二价烃基，Y代表-CO-、-S(O)-、-S(O)2-或键，环A代表可选取代的吡咯烷环、可选取代的哌啶环或可选取代的过氢杂环己烷环，Z1和Z3独立地代表键或可选取代的二价直链烃基，Z2代表-N(R1)-、-O-、-S(O)-、-S(O)2-、-CO-、-CH(R1)-或键，环B代表可选取代的咪唑环，其中可选取代的咪唑环所具有的取代基可以与R1一起形成可选取代的环，a代表0、1或2。
• Thiazoline derivative and use of the same
  申请人：Kubo Keiji

  公开号：US20070010528A1

  公开（公告）日：2007-01-11

  A thiazoline derivative represented by Formula (I): wherein R is a cyclic hydrocarbon group which may be substituted, or a heterocyclic group which may be substituted; X is a bond or a divalent chain hydrocarbon group which may be substituted; X′ is a bond or —N(R 5 )—; Y is a divalent hydrocarbon group which may be substituted; Y′ is a bond or —C(═O)—; ring A is a nitrogen-containing heterocycle which may be substituted; Z 1 and Z 3 are each independently a bond or a divalent chain hydrocarbon group which may be substituted; Z 2 is a bond or —N(R 6 )—; and B is a group represented by the formula: which is useful as a therapeutic drug for thrombosis, is provided.

  提供一种由式（I）表示的噻唑啉衍生物：其中R是环烃基，可以被取代，或者是可以被取代的杂环基; X是键或二价链烃基，可以被取代; X'是键或-N(R5)-; Y是二价烃基，可以被取代; Y'是键或-C(═O)-; 环A是含氮杂环，可以被取代; Z1和Z3各自独立地是键或二价链烃基，可以被取代; Z2是键或-N(R6)-; B是下式表示的基团：该化合物可用作治疗血栓症的药物。